Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Rana

Showing results (111-120 of 118) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 118 results.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2019
p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicityCarolina Torres, Georgina Mancinelli, Jose Cordoba-Chacon, et al.
Kidney Medicine|April 9, 2025
Resistance-Based Muscle Therapy, Frailty, and Muscle Biopsy Findings in Kidney Transplant Candidates: A Clinical TrialStephen T Bartlett, Ilaria Santi, Greg Hachaj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2015
PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab ResistanceKinnari Pandya, Debra Wyatt, Brian Gallagher, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2<sup>+</sup> breast cancer by ceramide-loaded nanoparticlesSandeep Kumar, Subhasis Das, Jingjing Sun, et al.
Journal of Medicinal Chemistry|June 10, 2026
Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPTGanga Reddy Velma, Sandeep Kumar, Piush Srivastava, et al.
Cancer Research|April 3, 2020
Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination ImmunotherapyDaniel R Principe, Matthew Narbutis, Sandeep Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
Scientific Reports|August 24, 2018
KRAS<sup>G12D</sup> and TP53<sup>R167H</sup> Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa PigsDaniel R Principe, Nana Haahr Overgaard, Alex J Park, et al.
Pageof 12

Showing results (111-120 of 118) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 118 results.
Proceedings of the National Academy of Sciences of the United States of America|July 4, 2019
p110γ deficiency protects against pancreatic carcinogenesis yet predisposes to diet-induced hepatotoxicityCarolina Torres, Georgina Mancinelli, Jose Cordoba-Chacon, et al.
Kidney Medicine|April 9, 2025
Resistance-Based Muscle Therapy, Frailty, and Muscle Biopsy Findings in Kidney Transplant Candidates: A Clinical TrialStephen T Bartlett, Ilaria Santi, Greg Hachaj, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2015
PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab ResistanceKinnari Pandya, Debra Wyatt, Brian Gallagher, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 12, 2022
Mixed lineage kinase 3 and CD70 cooperation sensitize trastuzumab-resistant HER2<sup>+</sup> breast cancer by ceramide-loaded nanoparticlesSandeep Kumar, Subhasis Das, Jingjing Sun, et al.
Journal of Medicinal Chemistry|June 10, 2026
Mixed Lineage Kinase Suppression in Triple-Negative Breast Cancer: Identification of a Dual Inhibitor Targeting MLK3 and NAMPTGanga Reddy Velma, Sandeep Kumar, Piush Srivastava, et al.
Cancer Research|April 3, 2020
Long-Term Gemcitabine Treatment Reshapes the Pancreatic Tumor Microenvironment and Sensitizes Murine Carcinoma to Combination ImmunotherapyDaniel R Principe, Matthew Narbutis, Sandeep Kumar, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 22, 2022
XP-524 is a dual-BET/EP300 inhibitor that represses oncogenic KRAS and potentiates immune checkpoint inhibition in pancreatic cancerDaniel R Principe, Rui Xiong, Yangfeng Li, et al.
Scientific Reports|August 24, 2018
KRAS<sup>G12D</sup> and TP53<sup>R167H</sup> Cooperate to Induce Pancreatic Ductal Adenocarcinoma in Sus scrofa PigsDaniel R Principe, Nana Haahr Overgaard, Alex J Park, et al.
Pageof 12